SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $424,814 | -51.5% | 59,681 | -30.6% | 0.00% | -50.0% |
Q2 2023 | $876,216 | +155.6% | 86,000 | +127.5% | 0.00% | +100.0% |
Q1 2023 | $342,841 | +1082.2% | 37,809 | +847.6% | 0.00% | – |
Q4 2022 | $29,000 | -9.4% | 3,990 | -19.0% | 0.00% | – |
Q3 2022 | $32,000 | +146.2% | 4,926 | +85.0% | 0.00% | – |
Q2 2022 | $13,000 | -38.1% | 2,663 | -26.8% | 0.00% | – |
Q1 2022 | $21,000 | +5.0% | 3,637 | -6.9% | 0.00% | – |
Q4 2021 | $20,000 | -20.0% | 3,907 | +1.3% | 0.00% | – |
Q3 2021 | $25,000 | +1150.0% | 3,857 | +980.4% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | -33.3% | 357 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | – | 357 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $23,410,000 | 5.89% |
AIGH Capital Management LLC | 642,154 | $3,924,000 | 0.71% |
Ikarian Capital, LLC | 1,095,024 | $6,690,000 | 0.54% |
Worth Venture Partners, LLC | 163,994 | $1,002,000 | 0.37% |
Orbimed Advisors | 4,797,148 | $29,311,000 | 0.30% |
RA Capital Management | 2,731,170 | $16,687,000 | 0.27% |
J. Goldman & Co LP | 720,877 | $4,405,000 | 0.17% |
DAFNA Capital Management LLC | 38,891 | $238,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 124,827 | $763,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,200 | $624,000 | 0.01% |